Study uses metabolomics to discriminate drug-induced liver injury phenotypes

Drug-induced liver injury (DILI) is an adverse reaction to ingesting a drug, which can appear both in developmental stages, in their clinical use and even after being approved as a drug.
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "Study uses metabolomics to discriminate drug-induced liver injury phenotypes"

Post a Comment